Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v2-FR
Language French French
Date Updated 2022-08-19 2022-01-12
Drug Identification Number 02487500 02487500
Brand name CABAZITAXEL FOR INJECTION CABAZITAXEL FOR INJECTION
Common or Proper name CABAZITAXEL CABAZITAXEL
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients CABAZITAXEL CABAZITAXEL
Strength(s) 60MG 60MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 60MG/6ML 1LIVI 60MG/6ML 1LIVI
ATC code L01CD L01CD
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2022-02-07 2022-01-24
Actual start date
Estimated end date Unknown Unknown
Actual end date 2022-08-18
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments